Effect of angiotensin II and small GTPase ras signaling pathway inhibition on early renal changes in a murine model of obstructive nephropathy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Rodríguez Peña, Ana B ^a,b   Fuentes Calvo, Isabel ^a   Docherty, Neil G ^a,c   Arévalo, Miguel ^d,e   Grande, María T ^a,f   Eleno, Nélida ^a,d   Pérez Barriocanal, Fernando ^a,d   López Novoa, José M ^a,d  

^a Instituto Reina Sofia de Investigacion Nefrologica   (Spain)

^b Centro de Investigacion del Cancer   (Spain)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA IBSAL   (Spain)

^e UNIVERSITY OF SALAMANCA   (Spain)

^f UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; CHAETOMELLIC ACID; CHAETOMELLIC ACID A; FIBRONECTIN; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN KINASE B; RAS PROTEIN; UNCLASSIFIED DRUG; ANGIOTENSIN 1 RECEPTOR; HEPTANOIC ACID DERIVATIVE; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; MALE; MOUSE; NONHUMAN; PROTEIN PRENYLATION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TREATMENT DURATION; TUBULOINTERSTITIAL FIBROSIS; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; DIET THERAPY; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; HUMAN; KIDNEY; KIDNEY DISEASES; METABOLISM; PATHOPHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; DISEASE MODELS, ANIMAL; FIBROSIS; HEPTANOIC ACIDS; HUMANS; KIDNEY; KIDNEY DISEASES; MICE; MONOMERIC GTP-BINDING PROTEINS; PYRROLES; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; URETERAL OBSTRUCTION;

EID: 84904640642     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/124902     Document Type: Article

References (51)

1. Ucero A. C., Benito-Martin A., Izquierdo M. C., Unilateral ureteral obstruction: beyond obstruction. International Urology and Nephrology 2014 46 4 765 776 10.1007/s11255-013-0520-1
2. Bascands J., Schanstra J. P., Obstructive nephropathy: insights from genetically engineered animals. Kidney International 2005 68 3 925 937 10.1111/j.1523-1755.2005.00486.x 2-s2.0-32644477571 (Pubitemid 43246409)
3. Klahr S., Ishidoya S., Morrissey J., Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. American Journal of Kidney Diseases 1995 26 1 141 146 10.1016/0272-6386(95)90167-1 2-s2.0-0029041733
4. Pimentel J. L. Jr., Montero A., Wang S., Yosipiv I., El-Dahr S., Martinez-Maldonado M., Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction. Kidney International 1995 48 4 1247 1253 10.1038/ki.1995.408 2-s2.0-0029150477
5. Pimentel J. L. Jr., Sundell C. L., Wang S., Kopp J. B., Montero Á., Martínez-Maldonado M., Role of angiotensin II in the expression and regulation of transforming growth factor- β in obstructive nephropathy. Kidney International 1995 48 4 1233 1246 10.1038/ki.1995.407 2-s2.0-0029102322
6. Esteban V., Lorenzo O., Rupérez M., Suzuki Y., Mezzano S., Blanco J., Kretzler M., Sugaya T., Egido J., Ruiz-Ortega M., Angiotensin II, via AT1 and AT2 receptors and NF- B pathway, regulates the inflammatory response in unilateral ureteral obstruction. Journal of the American Society of Nephrology 2004 15 6 1514 1529 10.1097/01.ASN.0000130564.75008.F5 2-s2.0-2542424673 (Pubitemid 38679676)
7. El Chaar M., Chen J., Seshan S. V., Jha S., Richardson I., Ledbetter S. R., Vaughan E. D. Jr., Poppas D. P., Felsen D., Effect of combination therapy with enalapril and the TGF- β antagonist 1D11 in unilateral ureteral obstruction. The American Journal of Physiology-Renal Physiology 2007 292 4 F1291 F1301 10.1152/ajprenal.00327.2005 2-s2.0-34147188133 (Pubitemid 46572449)
8. Kellner D., Chen J., Richardson I., Seshan S. V., Chaar M., Vaughan E. D. Jr., Poppas D., Felsen D., Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction. The Journal of Urology 2006 176 2 806 812 10.1016/j.juro.2006.03.076 2-s2.0-33745257020 (Pubitemid 43927915)
9. Klahr S., Morrissey J., Comparative effects of ACE inhibition and angiotensin II receptor blockade in the prevention of renal damage. Kidney International, Supplements 2002 62 82 S23 S26 2-s2.0-0036435796 (Pubitemid 35356991)
10. Chen C. O., Park M. H., Forbes M. S., Thornhill B. A., Kiley S. C., Kee H. Y., Chevalier R. L., Angiotensin-converting enzyme inhibition aggravates renal interstitial injury resulting from partial unilateral ureteral obstruction in the neonatal rat. American Journal of Physiology: Renal Physiology 2007 292 3 F946 F955 10.1152/ajprenal.00287.2006 2-s2.0-33847776370 (Pubitemid 46393420)
11. Coleman C. M., Minor J. J., Burt L. E., Thornhill B. A., Forbes M. S., Chevalier R. L., Angiotensin AT1-receptor inhibition exacerbates renal injury resulting from partial unilateral ureteral obstruction in the neonatal rat. The American Journal of Physiology-Renal Physiology 2007 293 1 F262 F268 10.1152/ajprenal.00071.2007 2-s2.0-34548029735 (Pubitemid 47345026)
12. Stoneking B. J., Hunley T. E., Nishimura H., Ma J., Fogo A., Inagami T., Tamura M., Adams M. C., Brock J. W. III, Kon V., Renal angiotensin converting enzyme promotes renal damage during ureteral obstruction. The Journal of Urology 1998 160 3 1070 1074 10.1016/S0022-5347(01)62699-5 2-s2.0-0032322336 (Pubitemid 29477748)
13. Aplin M., Christensen G. L., Hansen J. L., Pharmacologic perspectives of functional selectivity by the angiotensin II type 1 receptor. Trends in Cardiovascular Medicine 2008 18 8 305 312 10.1016/j.tcm.2009.01.003 2-s2.0-63449094061
14. Yin G., Yan C., Berk B. C., Angiotensin II signaling pathways mediated by tyrosine kinases. International Journal of Biochemistry and Cell Biology 2003 35 6 780 783 10.1016/S1357-2725(02)00300-X 2-s2.0-0037409235 (Pubitemid 36379319)
15. Chevalier R. L., Forbes M. S., Thornhill B. A., Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney International 2009 75 11 1145 1152 10.1038/ki.2009.86 2-s2.0-67349203391
16. Grande M. T., López-Novoa J. M., Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nature Reviews Nephrology 2009 5 6 319 328 10.1038/nrneph.2009.74 2-s2.0-68549091057
17. Rojas J. M., Santos E., Ras genes and human cancer: different implications and different roles. Current Genomics 2002 3 4 295 311 10.2174/1389202023350381 2-s2.0-0036302247 (Pubitemid 34752822)
18. Muthalif M. M., Karzoun N. A., Gaber L., Khandekar Z., Benter I. F., Saeed A. E., Parmentier J., Estes A., Malik K. U., Angiotensin II-induced hypertension contribution of Ras GTPase/mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 2000 36 4 604 609 10.1161/01.HYP.36.4. 604 2-s2.0-0033778488
19. Schieffer B., Paxton W. G., Chai Q., Marrero M. B., Bernstein K. E., Angiotensin II controls p21ras activity via pp60c-src. Journal of Biological Chemistry 1996 271 17 10329 10333 10.1074/jbc.271.17.10329 2-s2.0-0029985733 (Pubitemid 26131601)
20. Grande M. T., López-Novoa J. M., Therapeutical relevance of MAP-kinase inhibitors in renal diseases: current knowledge and future clinical perspectives. Current Medicinal Chemistry 2008 15 20 2054 2070 10.2174/092986708785132889 2-s2.0-53349110116
21. Martínez-Salgado C., Rodríguez-Peña A. B., López-Novoa J. M., Involvement of small Ras GTPases and their effectors in chronic renal disease. Cellular and Molecular Life Sciences 2008 65 3 477 492 10.1007/s00018-007-7260-2 2-s2.0-39149118348
22. Grande M. T., Arévalo M., Núñez A., Cannata-Andía J. B., Santos E., López-Novoa J. M., Targeted genomic disruption of H-ras and N-ras has no effect on early renal changes after unilateral ureteral ligation. World Journal of Urology 2009 27 6 787 797 10.1007/s00345-009-0399-8 2-s2.0-71349087020
23. Rodríguez-Peña A. B., Grande M. T., Eleno N., Arévalo M., Guerrero C., Santos E., López-Novoa J. M., Activation of Erk1/2 and Akt following unilateral ureteral obstruction. Kidney International 2008 74 2 196 209 10.1038/ki.2008.160 2-s2.0-46249118591 (Pubitemid 351915085)
24. Fuentes-Calvo I., Blázquez-Medela A. M., Eleno N., Santos E., López-Novoa J. M., Martínez-Salgado C., H-Ras isoform modulates extracellular matrix synthesis, proliferation, and migration in fibroblasts. American Journal of Physiology: Cell Physiology 2012 302 4 C686 C697 10.1152/ajpcell.00103.2011 2-s2.0-84856572782
25. Fuentes-Calvo I., Crespo P., Santos E., López-Novoa J. M., Martínez-Salgado C., The small GTPase N-Ras regulates extracellular matrix synthesis, proliferation and migration in fibroblasts. Biochimica et Biophysica Acta 2013 1833 12 2734 2744 10.1016/j.bbamcr.2013.07.008 2-s2.0-84882784817
26. Martínez-Salgado C., Fuentes-Calvo I., García-Cenador B., Santos E., López-Novoa J. M., Involvement of H-and N-Ras isoforms in transforming growth factor- β 1-induced proliferation and in collagen and fibronectin synthesis. Experimental Cell Research 2006 312 11 2093 2106 10.1016/j.yexcr.2006.03.008 2-s2.0-33744937083 (Pubitemid 43850934)
27. Grande M. T., Fuentes-Calvo I., Arevalo M., Heredia F., Santos E., Martínez-Salgado C., Rodríguez-Puyol D., Nieto M. A., López-Novoa J. M., Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice. Kidney International 2010 77 6 509 518 10.1038/ki.2009.498 2-s2.0-77949542468
28. Sharpe C. C., Dockrell M. E. C., Scott R., Noor M. I., Cowsert L. M., Monia B. P., Hendry B. M., Evidence of a role for Ki-RAS in the stimulated proliferation of renal fibroblasts. Journal of the American Society of Nephrology 1999 10 6 1186 1192 2-s2.0-0032994257 (Pubitemid 29246983)
29. Wang J., Newbury L. J., Knisely A. S., Monia B., Hendry B. M., Sharpe C. C., Antisense knockdown of Kras inhibits fibrosis in a rat model of unilateral ureteric obstruction. The American Journal of Pathology 2012 180 1 82 90 10.1016/j.ajpath.2011.09.036 2-s2.0-83455228625
30. Hancock J. F., Parton R. G., Ras plasma membrane signalling platforms. The Biochemical Journal 2005 389 1 1 11 10.1042/BJ20050231 2-s2.0-22144479017 (Pubitemid 40978001)
31. Masterson R., Kelynack K., Hewitson T., Becker G., Effect of inhibition of farnesylation and geranylgeranylation on renal fibrogenesis in vitro. Nephron-Experimental Nephrology 2006 102 1 e19 e29 10.1159/000088403 2-s2.0-32844462174 (Pubitemid 43250935)
32. Buemi M., Senatore M., Corica F., Aloisi C., Romeo A., Cavallaro E., Floccari F., Tramontana D., Frisina N., Statins and progressive renal disease. Medicinal Research Reviews 2002 22 1 76 84 10.1002/med.10000 2-s2.0-0036138105 (Pubitemid 34019902)
33. Jakobisiak M., Golab J., Potential antitumor effects of statins (Review). International Journal of Oncology 2003 23 4 1055 1069 2-s2.0-2542458153
34. Crul M., De Klerk G. J., Beijnen J. H., Schellens J. H. M. S., Ras biochemistry and farnesyl transferase inhibitors: a literature survey. Anti-Cancer Drugs 2001 12 3 163 184 10.1097/00001813-200103000-00001 2-s2.0-0035064177 (Pubitemid 32269912)
35. Ruocco A., Santillo M., Cicale M., Serù R., Cuda G., Anrather J., Iadecola C., Postiglione A., Avvedimento E. V., Paternò R., Farnesyl transferase inhibitors induce neuroprotection by inhibiting Ha-Ras signalling pathway. The European Journal of Neuroscience 2007 26 11 3261 3266 10.1111/j.1460-9568.2007.05935.x 2-s2.0-36248985034 (Pubitemid 350135180)
36. Qian Y., Sebti S. M., Hamilton A. D., Farnesyltransferase as a target for anticancer drug design. Biopolymers 1997 43 1 25 41 10.1002/(SICI)1097- 0282(1997)43:1<25::AID-BIP4>3.0.CO;2-2 2-s2.0-0030612442 (Pubitemid 127570809)
37. Rodríguez-Peña A. B., Santos E., Arévalo M., López-Novoa J. M., Activation of small GTPase Ras and renal fibrosis. Journal of Nephrology 2005 18 3 341 349 2-s2.0-23144455793 (Pubitemid 41078958)
38. Gharaee-Kermani M., Wiggins R., Wolber F., Goyal M., Phan S. H., Fibronectin is the major fibroblast chemoattractant in rabbit anti-glomerular basement membrane disease. The American Journal of Pathology 1996 148 3 961 967 2-s2.0-0030091604 (Pubitemid 126660687)
39. Serini G., Bochaton-Piallat M., Ropraz P., Geinoz A., Borsi L., Zardi L., Gabbiani G., The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor- β 1. The Journal of Cell Biology 1998 142 3 873 881 10.1083/jcb.142.3.873 2-s2.0-0031828004 (Pubitemid 28381502)
40. Masaki T., Foti R., Hill P. A., Ikezumi Y., Atkins R. C., Nikolic-Paterson D. J., Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney International 2003 63 4 1256 1264 10.1046/j.1523-1755.2003.00874.x 2-s2.0-0037378403 (Pubitemid 36349991)
41. Pat B., Yang T., Kong C., Watters D., Johnson D. W., Gobe G., Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney International 2005 67 3 931 943 10.1111/j.1523-1755.2005. 00157.x 2-s2.0-20844454775 (Pubitemid 41623317)
42. Moriyama T., Kawada N., Nagatoya K., Takeji M., Horio M., Ando A., Imai E., Hori M., Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney International 2001 59 6 2095 2103 10.1046/j.1523-1755.2001.0590062095.x 2-s2.0-0035007171 (Pubitemid 32467601)
43. Mizuguchi Y., Miyajima A., Kosaka T., Asano T., Hayakawa M., Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. The Journal of Urology 2004 172 6 I 2456 2459 10.1097/01.ju.0000138473.38447.f0 2-s2.0-8644242286 (Pubitemid 39507552)
44. Vieira J. M. Jr., Mantovani E., Tavares Rodrigues L., Dellê H., Noronha I. L., Fujihara C. K., Zatz R., Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrology Dialysis Transplantation- European Renal Association 2005 20 8 1582 1591 10.1093/ndt/gfh859 2-s2.0-26444478235 (Pubitemid 41418580)
45. Kamdar C., Chou S. Y., Mooppan U. M. M., Kim H., Gulmi F. A., Atorvastatin protects renal function in the rat with acute unilateral ureteral obstruction. Urology 2010 75 4 853 857 10.1016/j.urology.2009.05.030 2-s2.0-77950211888
46. Mazzei L. J., García I. M., Altamirano L., Docherty N. G., Manucha W., Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat. American Journal of Nephrology 2012 35 2 103 113 10.1159/000334935 2-s2.0-84855175616
47. Safina A. F., Varga A. E., Bianchi A., Zheng Q., Kunnev D., Liang P., Bakin A. V., Ras alters epithelial-mesenchymal transition in response to TGF β by reducing actin fibers and cell-matrix adhesion. Cell Cycle 2009 8 2 284 298 10.4161/cc.8.2.7590 2-s2.0-58549105508
48. Jordà M., Vinyals A., Marazuela A., Cubillo E., Olmeda D., Valero E., Cano A., Fabra À., Id-1 is induced in MDCK epithelial cells by activated Erk/MAPK pathway in response to expression of the Snail and E47 transcription factors. Experimental Cell Research 2007 313 11 2389 2403 10.1016/j.yexcr.2007.04.001 2-s2.0-34249986140 (Pubitemid 46891477)
49. Wei X., Wang X., Xia Y., Kindlin-2 regulates renal tubular cell plasticity by activation of Ras and its downstream signaling. American Journal of Physiology-Renal Physiology 2014 306 2 F271 F278
50. Peinado H., Quintanilla M., Cano A., Transforming growth factor β -1 induces Snail transcription factor in epithelial cell lines. Mechanisms for epithelial mesenchymal transitions. The Journal of Biological Chemistry 2003 278 23 21113 21123 10.1074/jbc.M211304200 2-s2.0-0038756636 (Pubitemid 36806424)
51. Sabbatini M., Santillo M., Pisani A., Paternò R., Uccello F., Serù R., Matrone G., Spagnuolo G., Andreucci M., Serio V., Esposito P., Cianciaruso B., Fuiano G., Avvedimento E. V., Inhibition of Ras/ERK1/2 signaling protects against postischemic renal injury. The American Journal of Physiology: Renal Physiology 2006 290 6 F1408 F1415 10.1152/ajprenal.00304.2005 2-s2.0-33744781526 (Pubitemid 43830766)